| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,912 | 39,269 | 39,375 | 40,912 | | Cost of Revenue | 11,649 | 12,796 | 14,631 | 15,751 | | | Gross Profit |
-
| 26,473 | 24,744 | 25,161 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,922 | 13,586 | 13,023 | 11,520 | | Non Recurring |
-
| (1) | 1 |
-
| | Others | 48,862 | 18,561 | 13,390 | 9,310 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (5,673) | (1,670) | 4,331 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (43,521) | (5,673) | (1,670) | 4,331 | | Interest Expense | 2,570 | 2,387 | 2,166 | 2,737 | | Income Before Tax | (46,091) | (8,060) | (3,836) | 1,594 | | Income Tax Expense | (16,204) | (2,876) | (1,427) | 252 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (29,887) | (5,184) | (2,409) | 1,342 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (29,887) | (5,184) | (2,409) | 1,342 | | Preferred Stock And Other Adjustments | (1,250) | (1,251) | (787) | (258) | | | Net Income Applicable To Common Shares | ($31,137) | ($6,435) | ($3,196) | $1,084 |
|
0.31% Nasdaq 0.00%
Income Statement
